| 10 Palmer KE, Benko A, Doucette SA et al. Protection of rabbits against cutaneous and mucosal papillomavirus infection using recombinant tobacco mosaic virus containing L2 … Z Duan, H Xu, X Ji, J Zhao, SJ Morris, S Sebastian, AJ Spencer, ... | | |
| 4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaques AJ Spencer, J Furze, JD Honeycutt, A Calvert, S Saurya, S Colloca, ... PLoS one 9 (8), e105520, 2014 | 11 | 2014 |
| A booster dose enhances Immunogenic ity of the COVID-19 vaccine candidate ChAdOx1 nCoV-19 in aged mice. Med 2: 243–262 A Silva-Cayetano, WS Foster, S Innocentin, S Belij-Rammerstorfer, ... | 3 | 2021 |
| A booster dose enhances immunogenicity of the COVID-19 vaccine candidate ChAdOx1 nCoV-19 in aged mice A Silva-Cayetano, WS Foster, S Innocentin, S Belij-Rammerstorfer, ... Med 2 (3), 243-262. e8, 2021 | 88 | 2021 |
| A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS, S/AS02A and MVA-CS SJ Dunachie, M Walther, JM Vuola, DP Webster, SM Keating, T Berthoud, ... Vaccine 24 (15), 2850-2859, 2006 | 123 | 2006 |
| A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria … SJ Dunachie, M Walther, JE Epstein, S Keating, T Berthoud, L Andrews, ... Infection and immunity 74 (10), 5933-5942, 2006 | 208 | 2006 |
| A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine DW Porter, FM Thompson, TK Berthoud, CL Hutchings, L Andrews, ... Vaccine 29 (43), 7514-7522, 2011 | 67 | 2011 |
| A monovalent chimpanzee adenovirus Ebola vaccine boosted with MVA K Ewer, T Rampling, N Venkatraman, G Bowyer, D Wright, T Lambe, ... New England Journal of Medicine 374 (17), 1635-1646, 2016 | 305 | 2016 |
| A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA EB Imoukhuede, R Payne, SK Fehling, T Strecker, N Biedenkopf, ... | | 2016 |
| A monovalent chimpanzee adenovirus Ebola vaccine—preliminary report T Rampling, K Ewer, G Bowyer, D Wright, E Imoukhuede, R Payne, ... New England Journal of Medicine, 2015 | 140 | 2015 |
| A multi-antigenic adenoviral-vectored vaccine improves BCG-induced protection of goats against pulmonary tuberculosis infection and prevents disease progression B Pérez de Val, E Vidal, B Villarreal-Ramos, SC Gilbert, A Andaluz, X Moll, ... PloS one 8 (11), e81317, 2013 | 47 | 2013 |
| A multi-antigenic adenoviral-vectored vaccine improves BCG-induced protection of goats against pulmonary tuberculosis infection and prevents disease progression. BP Val, E Vidal, B Villarreal-Ramos, SC Gilbert, A Andaluz, X Moll, ... | | 2013 |
| A multi-filovirus vaccine candidate: co-expression of Ebola, Sudan, and Marburg antigens in a single vector S Sebastian, A Flaxman, KM Cha, M Ulaszewska, C Gilbride, H Sharpe, ... Vaccines 8 (2), 241, 2020 | 18 | 2020 |
| A naturally protective epitope of limited variability as an influenza vaccine target CP Thompson, J Lourenço, AA Walters, U Obolski, M Edmans, DS Palmer, ... Nature communications 9 (1), 3859, 2018 | 39 | 2018 |
| A Novel Adenovirus (Adv)-Vaccinated Murine Model Simulates the Prothrombotic Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Clinical Disorder L Rauova, J Oberg, N Levine, K Bdeir, DB Cines, S Gilbert, M Poncz, ... Blood 142, 2631, 2023 | | 2023 |
| A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity MDJ Dicks, AJ Spencer, NJ Edwards, G Wadell, K Bojang, SC Gilbert, ... PloS one 7 (7), e40385, 2012 | 415 | 2012 |
| A novel multi-antigen virally vectored vaccine against Mycobacterium avium subspecies paratuberculosis TJ Bull, SC Gilbert, S Sridhar, R Linedale, N Dierkes, K Sidi-Boumedine, ... PLoS One 2 (11), e1229, 2007 | 52 | 2007 |
| A Phase 1b Clinical Trial to Determine the Safety, Tolerability and Immunogenicity of the Candidate Mycobacterium Avium Complex Subspecies Vaccines ChAdOx2 HAV and MVA HAV in … J Sanderson, J Aboagye, R Makinson, K Rapi, S Provstgaard-Morys, ... | | |
| A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya P Bejon, J Mwacharo, O Kai, T Mwangi, P Milligan, S Todryk, S Keating, ... PLoS clinical trials 1 (6), e29, 2006 | 184 | 2006 |
| A phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS E De Barra, SH Hodgson, KJ Ewer, CM Bliss, K Hennigan, A Collins, ... PloS one 9 (12), e115161, 2014 | 60 | 2014 |
Simon J DraperProfessor of Vaccinology and Translational Medicine, University of Oxford在 bioch.ox.ac.uk 的电子邮件经过验证
